ArticleJournal of the American Heart Association2021
Determinants of Morbidity and Mortality Associated With Isolated Tricuspid Valve Surgery.
Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.
- Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022Pooled it
- Clinical and Echocardiographic Outcomes of Transcatheter Tricuspid Valve Interventions: A Systematic Review and Meta-Analysis.Frontiers in cardiovascular medicine · 2022Pooled it
- Mid-Term Outcomes and Echocardiographic Predictors of TTVR: Insights from the TRAVEL Study.Journal of cardiovascular development and disease · 2026Article
- Explainable Lightweight AI for the Identification of Right-Sided Cardiac Dysfunction in a Saudi Arabian Diabetic Cohort.Journal of clinical medicine · 2026Article
- Behavior of mitral regurgitation after isolated tricuspid valve surgery: determinants and hemodynamic correlates.Journal of cardiothoracic surgery · 2026Article
- The impact of residual tricuspid regurgitation on long-term clinical outcomes, following tricuspid transcatheter edge-to-edge repair.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- Isolated secondary tricuspid regurgitation after left-sided valve surgery: impact on clinical outcomes.Open heart · 2026Observational
- In-Hospital Outcomes After Tricuspid Valve Surgery in the United States: Impact of Surgical Center Volumes.JACC. Advances · 2026Article
- Transcatheter Tricuspid Valve Replacement Versus Totally Thoracoscopic Beating-Heart Surgery for Tricuspid Regurgitation.Cardiovascular drugs and therapy · 2026Article
- Right Ventricular Function in Patients With Significant Tricuspid Regurgitation.Reviews in cardiovascular medicine · 2026Review
- The relationship between in-hospital mortality and Naples prognostic score in patients undergoing tricuspid valve surgery.Revista da Associacao Medica Brasileira (1992) · 2026Article
- Transcatheter valve repair of tricuspid regurgitation: 1-year outcomes from the TriCLASP study.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025Observational
- Right atrial remodelling and prognosis in patients with severe atrial functional tricuspid regurgitation.ESC heart failure · 2025Article
- Association of Diuretic Dosage With Outcomes in Patients With Hemodynamically Significant Isolated Tricuspid Valve Regurgitation.Journal of the American Heart Association · 2025Article
- Outcomes of isolated tricuspid replacement versus repair among older patients with tricuspid regurgitation in the United States.JTCVS open · 2025Article
- Impact of pulmonary hypertension and right ventricular function on outcomes of isolated tricuspid valve surgery.JTCVS open · 2025Article
- Pacemaker Implantation After Tricuspid Valve Surgery at a High-Volume Regional Reference Center.Annals of thoracic surgery short reports · 2024Article
- Transcatheter Tricuspid Regurgitation Repair-An Overview of Techniques and Eligible Patient Selection.Journal of clinical medicine · 2024Review
- Temporal Improvement in Outcomes of Surgical Treatment of Isolated Tricuspid Regurgitation in the United States.JACC. Advances · 2024Article
- Transcatheter Tricuspid Valve Clinical Trials: Incomplete Data and FDA-Approved Devices.Structural heart : the journal of the Heart Team · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Whether the poor outcomes of isolated tricuspid valve surgery are related to the operation itself or to certain patient characteristics including late referral is unknown. Methods and Results Adult patients who underwent isolated tricuspid valve surgery were identified in the Nationwide Readmissions Database (2016-2017). Patients who had redo tricuspid valve surgery, endocarditis, or congenital heart disease were excluded. Multivariable logistic regression was performed to identify contributors to postoperative mortality. A total of 1513 patients were included (mean age 55.7±16.6 years, 49.6% women). Surrogates of late referral were frequent: 41% of patients were admitted with decompensated heart failure, 44.3% had a nonelective surgery status, 16.8% had advanced liver disease, and 31% had an unplanned hospitalization in the prior 90 days. The operation was performed on day 0 to 1 of the hospitalization in only 50% of patients, and beyond day 10 in 22% of patients. In-hospital mortality occurred in 8.7% of patients. Median length of stay was 14 days (7-35 days), and median cost was $87 223 ($43 122-$200 872). In multivariable logistic regression analysis, surrogates for late referrals (acute heart failure decompensation, nonelective surgery status, or advanced liver disease) were the strongest predictors of in-hospital mortality (odds ratio [OR], 4.75; 95% CI, 2.74-8.25 [
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.